Bauer, C.; Göcerler, H.; Niculescu-Morzsa, E.; Jeyakumar, V.; Stotter, C.; Klestil, T.; Franek, F.; Nehrer, S. (2021). Biotribological Tests of Osteochondral Grafts after Treatment with Pro-Inflammatory Cytokines. Cartilage, Epub ahead of print: 10.1177/1947603521994900

Jeyakumar, V.; Amraish, N.; Niculescu-Morzsa, E.; Bauer, C.; Pahr, D.; Nehrer, S. (2021). Decellularized Cartilage Extracellular Matrix Incorporated Silk Fibroin Hybrid Scaffolds for Endochondral Ossification Mediated Bone Regeneration. International Journal of Molecular Sciences, 22(8): doi.org/10.3390/ijms22084055

Kazunori Shimomura, Hidetoshi Hamada, David A Hart, Wataru Ando, Takashi Nishii, Siegfried Trattnig, Stefan Nehrer, Norimasa Nakamura (2021). Histological Analysis of Cartilage Defects Repaired with an Autologous Human Stem Cell Construct 48 Weeks Postim-plantation Reveals Structural Details Not Detected by T2-Mapping MRI. Cartilage, 13(1_suppl): 694S-706S

Kuten-Pella, O.; De Luna, A.; Kramer, K.; Neubauer, M.; Nehrer, S.; Lacza, Z. (2021). Regenerative Potential of Blood-Derived Products in 3D Osteoarthritic Chondrocyte Culture System. Curr Issues Mol Biol, 43(2): 665-675

Moser, L; Bauer, C.; Jeyakumar, V.; Niculescu-Morzsa, E.; Nehrer, S. (2021). Hyaluronic Acid as a Carrier Supports the Effects of Glucocorticoids and Diminishes the Cytotoxic Effects of Local Anesthetics in Human Articular Chondrocytes In Vitro. International Journal of Molecular Sciences, 22: 10.3390/ijms222111503

Nehrer, S.; Neubauer, M. (2021). [Possibilities and limits of conservative treatment for osteoarthritis : Sport advice, training therapy, orthotics and cartilage therapeutics]. Orthopäde, 50(5): 346-355

Neubauer, M.; Nehrer, S. (2021). Apophyseal injuries in sports. Orthopade, 50(2): 163-171

Olmos Calvo, I.; Fodor, E.; Kardos, D.;Hornyák, I.; Hin-senkamp, A.; Kuten-Pella, O.; Gyevnár, Z.; Erdélyi, G.; Bárdos, T.; Mirkó Pau-kovits, T.; Magos, K.; Béres, G.; Nehrer, S.; Lacza, Z. (2021). Pilot Clinical Study of Hyperacute Serum Treatment in Osteoarthritic Knee Joint: Cytokine Chang-es and Clinical Effects. Curr Issues Mol Biol., 43(2): 637-649

Olmos Calvo, I.; Kuten-Pella, O.; Kramer, K.; Madár, À.; Takács, S.; Kardos, D.; Simon, D.; Erdö-Bonyár, S.; Berki, T.; De Luna, A.; Nehrer, S.; Lacza Z. (2021). Optimization of Lyophilized Hyperacute Serum (HAS) as a Regenerative Therapeutic in Osteoarthritis. Int J Mol Sci, 22 (14): 7496

Otahal, A.; Kramer, K.; Kuten-Pella, O.; Moser, L.; Neubauer, M.; Lacza,Z.; Nehrer, S.; De Luna, A. (2021). Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model. Int J Mol Sci., 22(13): 7224

Otahal, A.; Kuten-Pella, O.; Kramer, K.; Neubauer, M.; Lacza, Z.; Nehrer, S.; De Luna, A. (2021). Functional repertoire of EV-associated miRNA profiles after lipoprotein depletion via ultracentrifugation and size exclusion chromatography from autologous blood products. Sci Rep., 12;11(1): 5823

De Luna, A.; Otahal, A.; Nehrer, S. (2020). Mesenchymal Stromal Cell-Derived Extracellular Vesicles - Silver Linings for Cartilage Regeneration? Frontiers in Cell and Developmental Biology, 8:593386: 10.3389/fcell.2020.593386

Filardo, G.; Andriolo, L.; Angele, P.; Berruto, M.; Brittberg, M.; Condello, V.; Chubinskaya, S.; de Girolamo, L.; Di Martino, A.; Di Matteo, B.; Gille, J.; Gobbi, A.; Lattermann, C.; Nakamura, N.; Nehrer, S.; Peretti, GM.; Shabshin, N.; Verdonk, P.; Zaslav, K.; Kon, E. (2020). Scaffolds for Knee Chondral and Osteochondral Defects: Indications for Different Clini-cal Scenarios. A Consensus Statement. Cartilage, 15: 10.1177/1947603519894729.

Kon, E.; Engebretsen, L.; Verdonk, P.; Nehrer, S.; Filardo, G. (2020). Autologous Protein Solution Injections for the Treatment of Knee Osteoarthritis: 3-Year Results. Am J Sports Med, 48(11): 2703-2710

Otahal, A.; Kramer, K.; Kuten-Pella, O.; Weiss, R.; Stotter, C.; Lacza, Z.; Weber, V.; Nehrer, S.; De Luna, A. (2020). Characterization and chondroprotective effects of extracellular vesicles from plasma- and serum-based autologous blood-derived products for osteoarthritis therapy. Front Bioeng Biotechnol, Sep 25: 584050

Load more
from
Back to top